Viela Bio: Viela Bio closes its $3.05B sale. Here's what's next for its leadership team.
The Gaithersburg drug developer had announced the deal barely two months ago.
Read full article »
Viela Bio is a Maryland-based biotechnology company that develops and commercializes therapeutics for autoimmune and severe inflammatory diseases.
Read more